Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Patients and Physical Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05002868
What this trial is testing

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Who this might be right for
Solid TumorExtensive-stage Small-cell Lung CancerLocally Advanced Breast Cancer+4 more
Rhizen Pharmaceuticals SA 23
Not applicableStudy completedNCT00253643
What this trial is testing

Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer

Who this might be right for
Precancerous ConditionProstate Cancer
OHSU Knight Cancer Institute 89
Large-scale testing (Phase 3)Ended earlyNCT01805791
What this trial is testing

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hutchison Medipharma Limited 201
Not applicableLooking for participantsNCT05778708
What this trial is testing

Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients

Who this might be right for
Advanced Lung Non-Small Cell Carcinoma
The University of Hong Kong 318
Early research (Phase 1)UnknownNCT04689308
What this trial is testing

This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Minghui Pharmaceutical (Shanghai) LTD 57
Testing effectiveness (Phase 2)Study completedNCT02138955
What this trial is testing

A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer

Who this might be right for
Patients w/Advanced Cancer That Failed Std of Care Therapy
SignPath Pharma, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT05160168
What this trial is testing

THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors (GIST)Neoplasms, Connective TissueNeoplasms, Connective and Soft Tissue+6 more
Theseus Pharmaceuticals 32
Not applicableStudy completedNCT03743740
What this trial is testing

The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Hacettepe University 10
Not applicableUnknownNCT06366685
What this trial is testing

Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After Esophagectomy

Who this might be right for
Esophageal CancerExercise TrainingPsychotherapy+1 more
Mengmeng Yuan 60
Not applicableNot Yet RecruitingNCT07212517
What this trial is testing

Benson Relaxation Exercises and Sleep Quality in Lung Cancer Patients

Who this might be right for
Sleep QualityRelaxationCanser+1 more
Uskudar University 60
Early research (Phase 1)UnknownNCT06433726
What this trial is testing

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Chengdu Baiyu Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Testing effectiveness (Phase 2)Looking for participantsNCT07193511
What this trial is testing

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+1 more
Avenzo Therapeutics, Inc. 355
Testing effectiveness (Phase 2)Study completedNCT01516593
What this trial is testing

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

Who this might be right for
HIVBurkitt's Lymphoma
Andres J. M. Ferreri 19
Early research (Phase 1)Study completedNCT05775406
What this trial is testing

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Who this might be right for
Myeloid MalignanciesAcute Lymphocytic LeukemiaLymphomas+1 more
Kymera Therapeutics, Inc. 52
Early research (Phase 1)Study completedNCT01226316
What this trial is testing

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Who this might be right for
Advanced Solid MalignancySafety and TolerabilityPharmacokinetics+11 more
AstraZeneca 285
Early research (Phase 1)Study completedNCT01792687
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 6
Not applicableLooking for participantsNCT07465393
What this trial is testing

Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors

Who this might be right for
Breast NeoplasmsSarcopenia
Valeria Chiu 66
Early research (Phase 1)Study completedNCT02004106
What this trial is testing

Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 110
Early research (Phase 1)Not Yet RecruitingNCT07583316
What this trial is testing

First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more
Corregene Biotechnology Co., Ltd 192
Next Page